• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Drugs Context . Key policy and programmatic factors to improve influenza vaccination rates based on the experience from four high-performing countri

tetano

Editor, Senior Moderator
Drugs Context


. 2021 Jan 5;10:2020-9-5.
doi: 10.7573/dic.2020-9-5. eCollection 2021.
Key policy and programmatic factors to improve influenza vaccination rates based on the experience from four high-performing countries


George Kassianos[SUP] 1 [/SUP], Ashis Banerjee[SUP] 2 [/SUP], Florence Baron-Papillon[SUP] 3 [/SUP], Alan W Hampson[SUP] 4 5 [/SUP], Janet E McElhaney[SUP] 6 [/SUP], Allison McGeer[SUP] 7 8 [/SUP], Thierry Rigoine de Fougerolles[SUP] 9 [/SUP], Mitch Rothholz[SUP] 10 [/SUP], Holly Seale[SUP] 11 [/SUP], Litjen J Tan[SUP] 12 [/SUP], Angus Thomson[SUP] 3 [/SUP], Olivier Vitoux[SUP] 9 [/SUP]



Affiliations
Free PMC article

Abstract

Background: Many countries consistently fail to achieve the target influenza vaccine coverage rate (VCR) of 75% for populations at risk of complications, recommended by the World Health Organization and European Council. We aimed to identify factors for achieving a high VCR in the scope of four benchmark countries with high influenza VCRs: Australia, Canada, UK and USA.
Methods: Publicly available evidence was first reviewed at a global level and then for each of the four countries. Semi-structured interviews were then conducted with stakeholders meeting predefined criteria. Descriptive cluster analyses were performed to identify key factors and pillars for establishing and maintaining high VCRs.
Results: No single factor led to a high VCR, and each benchmark country used a different combination of tailored approaches to achieve a high vaccine coverage. In each country, specific triggers were important to stimulate changes that led to improved vaccine coverage. A total of 42 key factors for a successful influenza vaccination programme were identified and clustered into five pillars: (1) Health Authority accountability and strengths of the influenza programme, (2) facilitated access to vaccination, (3) healthcare professional accountability and engagement, (4) awareness of the burden and severity of disease and (5) belief in influenza vaccination benefit. Each benchmark country has implemented multiple factors from each pillar.
Conclusion: A wide range of factors were identified from an evaluation of four high-performing benchmark countries, classified into five pillars, thus providing a basis for countries with lower VCRs to tailor their own particular solutions to improve their influenza VCR.

Keywords: benchmark; influenza vaccine; vaccine coverage rate.
 
Back
Top Bottom